-
February 11, 2013
Warner Chilcott (WCRX) recently revealed its financial guidance for 2013. The company expects to earn $3.20-$3.30 ...
-
February 06, 2013
ArQule, Inc. (ARQL) and partner Daiichi Sankyo recently announced that former has enrolled the first patient for the ...
-
January 31, 2013
Pluristem Therapeutics, Inc. (PSTI) recently announced that it has taken possession of its new state-of-the-art ...
-
January 07, 2013
Israel-based Pluristem Therapeutics, Inc. (PSTI) recently announced the initiation of the final validation steps for ...
-
December 31, 2012
We recently reiterated a Neutral recommendation on United Therapeutics (UTHR). While the company reported strong ...
-
December 18, 2012
Switzerland-based Actelion (ALIOF) recently announced that the US Food and Drug Administration (FDA) accepted its ...
-
December 13, 2012
This morning has been rocky for the market. The Nasdaq is down 0.4%; the S&P 500 has declined 0.3%; and the Dow has ...
-
December 13, 2012
The Nasdaq has decreased 0.4%, the S&P 500 has fallen 0.3% and the Dow is down 0.2% on a bad morning for the market. ...
-
November 28, 2012
Currently, the Nasdaq has remained steady, the S&P 500 has increased 0.1% and the Dow is up 0.2%. The healthcare ...
-
November 26, 2012
The European Medicines Agency (EMA) recently accepted the Marketing Authorisation Application (MAA) filed by ...
-
November 05, 2012
The Nasdaq has moved up 0.1%, the S&P 500 has declined 0.3% and the Dow has slipped 0.3% so far today. The ...
-
November 02, 2012
United Therapeutics Corp. (UTHR) reported third-quarter earnings of $1.46 per share, well above the year-ago ...
-
October 30, 2012
We recently downgraded United Therapeutics (UTHR) to a Neutral recommendation with a $48.00 target price. United ...
-
October 29, 2012
Switzerland-based Actelion (ALIOF) recently submitted a New Drug Application (NDA) to the US Food and Drug ...
-
October 24, 2012
The Nasdaq has remained steady, the S&P 500 is up 0.1% and the Dow has moved up 0.3% so far today. The recent surge ...
-
October 24, 2012
So far today, the Nasdaq remains relatively unchanged, the S&P 500 has risen 0.1% and the Dow has climbed 0.3%. The ...
-
October 19, 2012
Switzerland-based Actelion (ALIOF) reported third quarter 2012 earnings of $1.17 per American Depository Receipt ...
-
October 15, 2012
Arena Pharmaceuticals, Inc. (ARNA) recently initiated a phase I multiple dose study with APD811, which is being ...
-
October 15, 2012
United Therapeutics Corporation (UTHR) performed above expectations in the first half of 2012 and is positioned to ...
-
October 02, 2012
So far today, the Nasdaq has climbed 0.4%, the S&P 500 is up 0.1% and the Dow is trading down 0.2%. The healthcare ...
